Enveric Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Enveric Biosciences, Inc. (ENVB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-9.57-17.29-18.47-48.98-6.86
Depreciation & Amortization0.340.410.440.680.12
Deferred Income Tax0.000.00-1.50-7.450.00
Stock Based Compensation1.562.152.6212.631.98
Change in Working Capital-0.42-0.17-0.221.19-0.37
Change in Accounts Payable-0.83-0.100.260.380.27
Change in Other Working Capital0.411.85-0.480.80-0.64
Other Operating Activities0.371.85-8.97-15.660.96
Net Cash from Operating Activities-7.73-14.09-17.15-11.46-3.89
Investing Activities
Capital Expenditures0.00-0.01-0.58-0.190.00
Acquisitions0.000.000.003.060.00
Sales/Maturities of Investments0.000.000.00-0.68-0.04
Net Cash from Investing Activities0.000.01-0.582.19-0.04
Financing Activities
Debt Repayment0.000.000.000.00-0.19
Common Stock Issued2.290.0017.2224.903.86
Common Stock Repurchased1.08-1.050.000.000.00
Other Financing Activities4.30-0.290.960.000.00
Net Cash from Financing Activities7.67-1.3418.1824.905.53
Summary
Effect of Forex Changes on Cash0.01-0.01-0.080.140.00
Net Change in Cash-0.05-15.430.3715.781.53
Cash at Beginning of Period2.2917.7217.361.580.00
Cash at End of Period2.242.2917.7217.360.00
Free Cash Flow-7.73-14.10-17.73-11.65-3.89
Supplemental Disclosures
Interest Paid0.000.000.010.010.00
Income Taxes Paid0.010.010.000.000.00